Agreement Signed for Production of Anti-VISTA Antibody for Cancer Clinical Trial
Innovative biotherapeutics company, Hummingbird Bioscience announced a partnership with Mycenax Biotech to produce anti-VISTA antibody, HMBD-002 for use in Phase I clinical trials of its HMBD-002...